CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
October 2017—PerkinElmer is collaborating with In-Depth Genomics to support IDG’s whole genome sequencing diagnostic program, which will bring genetic diagnosis to patients who have a wide range of neurological conditions, including orphan disorders, and aims to provide improved diagnoses and treatments.
IDG will offer its program to any U.S. physician and will fund the initiative at no cost to the patient. The program plans to sequence 100,000 genomes of patients who suffer from rare and undiagnosed conditions. PerkinElmer Genetics will provide clinical whole genome sequencing, interpretation services, and diagnostic report generation to IDG. IDG will use the de-identified genomic and clinical data to support research and development in hundreds of rare neurological conditions.
In-Depth Genomics, 425-679-1225
PerkinElmer, 203-925-4602